Rici Healthcare Holdings Limited
Symboli: 1526.HK
HKSE
1.15
HKDMarkkinahinta tänään
4.4392
P/E-suhde
-0.0263
PEG-suhde
1.83B
MRK Cap
- 0.13%
DIV Tuotto
Rici Healthcare Holdings Limited (1526-HK) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 811.2 | 720.1 | 784.4 | |||||||||||
balance-sheet.row.short-term-investments | 0 | 11.9 | 0 | 13.1 | |||||||||||
balance-sheet.row.net-receivables | 0 | 299.5 | 278.7 | 346.7 | |||||||||||
balance-sheet.row.inventory | 0 | 37.4 | 56 | 61.7 | |||||||||||
balance-sheet.row.other-current-assets | 0 | 270 | 301.4 | 249 | |||||||||||
balance-sheet.row.total-current-assets | 0 | 1438.6 | 1356.3 | 1441.7 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2824.9 | 2664.1 | 2774.3 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 0 | 20.7 | 5.4 | 10.9 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 20.7 | 5.4 | 10.9 | |||||||||||
balance-sheet.row.long-term-investments | 0 | 193.7 | 192.3 | 10.2 | |||||||||||
balance-sheet.row.tax-assets | 0 | 109.9 | 124.8 | 213.5 | |||||||||||
balance-sheet.row.other-non-current-assets | 0 | 50 | -124.8 | -213.5 | |||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3199.2 | 2861.8 | 2795.3 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 348.7 | 299.1 | |||||||||||
balance-sheet.row.total-assets | 0 | 4637.8 | 4566.9 | 4536.2 | |||||||||||
balance-sheet.row.account-payables | 0 | 164.4 | 171 | 189.3 | |||||||||||
balance-sheet.row.short-term-debt | 0 | 911.8 | 880.7 | 1064.2 | |||||||||||
balance-sheet.row.tax-payables | 0 | 114.3 | 72.4 | 64.7 | |||||||||||
balance-sheet.row.long-term-debt-total | 0 | 1354.8 | 320.2 | 474.7 | |||||||||||
Deferred Revenue Non Current | 0 | 3.7 | 90.3 | 94.1 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 0 | 1353.3 | 1982.9 | 1840.8 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1358.5 | 320.2 | 474.7 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 1188 | 1444 | |||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1399.9 | 1363.2 | 1494.4 | |||||||||||
balance-sheet.row.total-liab | 0 | 3523.7 | 3662 | 3948.8 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 220.8 | 206.4 | |||||||||||
balance-sheet.row.common-stock | 0 | 1.1 | 1.1 | 1.1 | |||||||||||
balance-sheet.row.retained-earnings | 0 | 517.4 | 458.3 | 167.6 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1125.9 | -220.8 | -206.4 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -517.4 | 494.5 | 508.9 | |||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1126.9 | 953.9 | 677.5 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4637.8 | 4566.9 | 4536.2 | |||||||||||
balance-sheet.row.minority-interest | 0 | -12.9 | -49.1 | -90.1 | |||||||||||
balance-sheet.row.total-equity | 0 | 1114 | 904.8 | 587.4 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||
Total Investments | 0 | 193.7 | 192.3 | 23.3 | |||||||||||
balance-sheet.row.total-debt | 0 | 2266.6 | 2298.6 | 2743.3 | |||||||||||
balance-sheet.row.net-debt | 0 | 1455.3 | 1578.4 | 1972 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 363.8 | 290.8 | 181.6 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 356.7 | 367.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 43.6 | 69.4 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | -3.2 | 10.9 | 16.9 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -54.5 | -86.2 | |||||||||||
cash-flows.row.account-receivables | 0 | 0 | -63.8 | -78.9 | |||||||||||
cash-flows.row.inventory | 0 | 0 | 9.2 | -7.3 | |||||||||||
cash-flows.row.account-payables | 0 | 0 | 4.7 | 4.8 | |||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | -360.6 | 58.9 | 131.8 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -310 | -324.7 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 128 | 0 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -180 | 0 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 52 | 0 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 36.1 | 55.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -274 | -269.1 | |||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -1763.7 | -1052.3 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 1268.5 | 858.3 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | -495.2 | -194 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 11.7 | -8.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | -51.1 | 209.4 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 720.1 | 720.1 | 771.3 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 720.1 | 771.3 | 561.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 706.4 | 681.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -310 | -324.7 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 396.3 | 356.4 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 2992.7 | 2375 | 2377.2 | |||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1743.2 | 1447.8 | 1402 | |||||||||||
income-statement-row.row.gross-profit | 0 | 1249.5 | 927.2 | 975.2 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | 0 | 7.4 | -3.2 | 11.3 | |||||||||||
income-statement-row.row.operating-expenses | 0 | 590.3 | 483.4 | 466.5 | |||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2333.5 | 1931.2 | 1868.5 | |||||||||||
income-statement-row.row.interest-income | 0 | 10.4 | 116.6 | 116.6 | |||||||||||
income-statement-row.row.interest-expense | 0 | 127.1 | 123.1 | 123.5 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -111.3 | -104.8 | -128.6 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | 0 | 7.4 | -3.2 | 11.3 | |||||||||||
income-statement-row.row.total-operating-expenses | 0 | -111.3 | -104.8 | -128.6 | |||||||||||
income-statement-row.row.interest-expense | 0 | 127.1 | 123.1 | 123.5 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 396.8 | 140.7 | 162.1 | |||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 0 | 656.9 | 431.9 | 520.7 | |||||||||||
income-statement-row.row.income-before-tax | 0 | 545.6 | 327.2 | 392.1 | |||||||||||
income-statement-row.row.income-tax-expense | 0 | 143.7 | 84 | 98.4 | |||||||||||
income-statement-row.row.net-income | 0 | 363.8 | 290.8 | 349.1 |
Usein kysytty kysymys
Mikä on Rici Healthcare Holdings Limited (1526.HK) taseen loppusumma?
Rici Healthcare Holdings Limited (1526.HK) kokonaisvarat ovat 4637755000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.418.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 0.306.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.122.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.220.
Mikä on Rici Healthcare Holdings Limited (1526.HK) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 363803000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 2266551000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 590326000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.